US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

39.67

+0.41001.04%

Pre-market: 39.910.2400+0.60%04:00 EDT

Volume:75.38K

Turnover:2.97M

Market Cap:259.84M

PE:- -

High:39.69

Open:39.05

Low:39.05

Close:39.26

52wk High:41.49

52wk Low:22.18

Shares:6.55M

Float Shares:6.55M

Volume Ratio:0.54

T/O Rate:1.15%

Dividend:0.28

Dividend Rate:0.71%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Top 10 Best-Performing US Stocks in August: Moderna Surges 156%, Palantir Leads AI Software Stocks

Vertex Advances Share Buyback, Acquires 445,500 Shares by August

Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run

Simply Wall St.

Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s Disease

Incyte Reaches CMS Pact on Jakafi Medicaid Pricing

NeuroThera Labs Advances Enrollment in Autism Drug Trial for SCI-210

Incyte - Expects Exemption from Future CMS Pricing Mandates Including Guard and Globe - SEC Filing

THOMSON REUTERS

Incyte - Announces Agreement with CMS to Improve Medicine Access - SEC Filing

THOMSON REUTERS

Incyte - State Medicaid to Access Jakafi and Jakafi Xr at Prices Aligned with Advanced Nations - SEC Filing

THOMSON REUTERS

Incyte - Does not Expect Agreement to Affect 2026 Financial Guidance or Outlook - SEC Filing

THOMSON REUTERS

SciSparc subsidiary provides update on SCI-210 trial enrollment

PMV Pharmaceuticals announces updated ovarian cancer data from PYNNACLE trial

Cboe data suggests bullish flow in Moderna with shares up 0.71%

Moderna Stock (MRNA) Was the Best Performer in August

Revolution Medicines, Inc. : Needham Raises Target Price to $275 from $240

THOMSON REUTERS

Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

Tenax Therapeutics announces results from Phase 3 LEVEL trial of TNX-103

Incyte (INCY) Stock Could Be 31% Stretched Following KRAS Data Buzz

Simply Wall St.

August Turmoil: Bessent's Intervention and the Quiet Reveal of Policy's Hidden Hand

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Spyre Therapeutics (SYRE)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/IDNA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IDNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","market":"US","secType":"STK","nameCN":"iShares Genomics Immunology and Healthcare ETF","latestPrice":39.67,"timestamp":1788292800000,"preClose":39.26,"halted":0,"volume":75380,"hourTrading":{"tag":"盘前","latestPrice":39.91,"preClose":39.67,"latestTime":"04:00 EDT","volume":5,"amount":199.54999999999998,"timestamp":1788336002761,"change":0.24,"changeRate":0.00605,"amplitude":0},"delay":0,"changeRate":0.010443199184921134,"floatShares":6550000,"shares":6550000,"eps":0,"marketStatus":"Pre-Mkt","change":0.41,"latestTime":"09-02 07:42:59 EDT","open":39.05,"high":39.6899,"low":39.05,"amount":2972722.6162,"amplitude":0.016299,"askPrice":39.84,"askSize":20,"bidPrice":33.43,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788355800000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":39.67,"sharesOutstanding":5100000,"nav":39.190942,"aum":256700670.1,"dividendRate":0.007131,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":39.91,"preClose":39.67,"latestTime":"04:00 EDT","volume":5,"amount":199.54999999999998,"timestamp":1788336002761,"change":0.24,"changeRate":0.00605,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":35.74,"preClose":39.67,"latestTime":"19:30 EDT","volume":829,"amount":32033.95,"timestamp":1788305400694,"change":-3.93,"changeRate":-0.099067,"amplitude":0.099067},"volumeRatio":0.5417424869162961,"impliedVol":0.0718,"impliedVolPercentile":0.0598},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","floatShares":6550000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5417424869162961,"shares":6550000,"dividePrice":0.2829,"high":39.6899,"amplitude":0.016299,"preClose":39.26,"low":39.05,"week52Low":22.18,"pbRate":"--","week52High":41.49,"institutionHeld":0,"latestPrice":39.67,"committee":0.666667,"eps":0,"divideRate":0.007131,"volume":75380,"delay":0,"ttmEps":0,"open":39.05,"prevYearClose":26.19,"prevWeekClose":39.29,"prevMonthClose":39.26,"prevQuarterClose":33.75,"fiveDayClose":41.48,"twentyDayClose":32.9055,"sixtyDayClose":29.14},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDNA\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IDNA","amount":0.125421,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2025-12-16","symbol":"IDNA","amount":0.155456,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"IDNA","amount":0.152909,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"IDNA","amount":0.11105,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"IDNA","amount":0.11144,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDNA\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-16","recordDate":"2019-12-17","paymentDate":"2019-12-20","value":0.237063,"currency":"USD"},{"executeDate":"2020-06-15","recordDate":"2020-06-16","paymentDate":"2020-06-19","value":0.083667,"currency":"USD"},{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-18","value":0.036209,"currency":"USD"},{"executeDate":"2021-06-10","recordDate":"2021-06-11","paymentDate":"2021-06-16","value":0.052145,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-17","value":0.256358,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDNA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDNA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664836115","title":"Top 10 Best-Performing US Stocks in August: Moderna Surges 156%, Palantir Leads AI Software Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2664836115","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664836115?lang=en_us&edition=fundamental","pubTime":"2026-09-01 14:51","pubTimestamp":1788245470,"startTime":"0","endTime":"0","summary":"TradingKey - In August 2026, the upward momentum in US stocks broadened significantly. Moderna (MRNA) topped the S&P 500 constituents with a 156% gain, surging 375.9% year-to-date. Palantir (PLTR) followed closely behind, rising 51.5% in August, while enterprise software stocks as a whole extended their previous recovery.","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230915/5159981a89101d628f3e4c33ac20272e.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230915/5159981a89101d628f3e4c33ac20272e.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262143172-top-10-best-performing-us-stocks-august-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1496350502.SGD","BK4551","BK4561","BK4532","LU1366333091.USD","LU2264538146.SGD","LU0648001328.SGD","PLTW","LU2271345857.HKD","LU0345781412.USD","LU2063271972.USD","BK4503","LU1823568750.SGD","LU1496350171.SGD","LU1430597077.USD","BK4566","LU0823434740.USD","COWG","LU0980610538.SGD","FSMD","LU1861559042.SGD","LU2362541273.HKD","LU1923622614.USD","LU2265009873.SGD","LU1803068979.SGD","BK4134","SNDQ","BK4023","LU0724618789.USD","LU0130103400.USD","LU0265550946.USD","LU1223082519.USD","LU2247934214.USD","LU0124676726.USD","LU0170899867.USD","SG9999001143.SGD","LU1153585028.USD","SPLTRmain","LU2433249047.HKD","LU0011850046.USD","SNXX","LGHT","LU1988902786.USD","LU1064131342.USD","BK4528","LU0496367417.USD","LU0742534661.SGD","LU1267930813.SGD","PLTU","LU1201861249.SGD","LU0820562030.AUD","LU0265550359.USD","LU0289961442.SGD","LU0289739699.SGD","LU1235294995.USD","LU0557290698.USD","LU2362541513.USD","SMCY","LU0316494557.USD","LU0109392836.USD","LU2089283258.USD","LU0300736062.USD","BK4598","LU0963586101.USD","BK4527","LU2125909916.SGD","LU1720051108.HKD","LU2286300806.USD","BK4579","PTF","BK4613","LU1917777945.USD","LU0127658192.USD","OPTZ","BK4504","LU0300736492.USD","DISK","IE00B19Z8X17.USD","LU2517655028.SGD","NEMG","PLTA","SHLD","GNOM","SMCZ","LU0130102774.USD","SMYY","IE00B19Z8W00.USD","BK4534","PLOO","LU0238689110.USD","LU0211327993.USD","NWMX","LU0348723411.USD","BK4585","LU1791710582.SGD","BK4588","LU2125909247.SGD","LU0612318385.USD","IDNA","LU2023251221.USD","CRMG","LU2517655291.USD","LU1116320737.USD","PLTI","LU1046421795.USD","BK4538","LU1951200564.SGD","IE0002270589.USD","LU0345780281.USD","LU0187121727.USD","LU2106854487.HKD","BK4139","LU0353189763.USD","CLOD","LU2125909593.SGD","MRNY","LU0314104364.USD","BK4607","LU2244417387.USD","BK4568","LU0128525689.USD","LU1720051017.SGD","LU0320765059.SGD","LU2756315318.SGD","FCUS","IE00BZ1G4Q59.USD","LU1989764664.SGD","LU1551013425.SGD","NOW","GDX","LU1951198990.SGD","SCHM","BK4547","LU0158827781.USD","SGDM","NOWL","LU1814569148.SGD","PLTD","LU1989764748.USD","GUNZ","LU2361045086.USD","LU0057025933.USD","LU0058720904.USD","LU1551013342.USD","PLTR","LU2498475776.HKD","LU1861220033.SGD","LU1923622291.USD","SNDC","LU0289739343.SGD","LU0689472784.USD","IGV","BK4501","LU0158827948.USD","IE00B19Z3B42.SGD","PLTZ","LU2111349929.HKD","AIPI","LU1883866441.USD","IE00BMPRXN33.USD","LU0130518102.USD","IE00B19Z9505.USD","SNDK","LU0792757196.USD","LU0267386448.USD","LU0266512473.USD","SMCL","BK4505","LU0310800965.SGD","SMCX","LU2023250843.SGD","PLTG","LU0006306889.USD","BK4608","BK4581","LU1267930730.SGD","BK4548","LU0672654240.SGD","VEEV","LU0642271901.SGD","LU0157215616.USD","BK4570","LU2756315664.SGD","LU2517655374.HKD","LU0354030511.USD","LU2087625088.SGD","LU1223082196.USD","LU0353189680.USD","LU0345780950.USD","LU0211328371.USD","EKG","LU0048573561.USD","LU0788109121.HKD","LU1974910355.USD","LU2361044865.SGD","MRNX","BK4535","LU2543165471.USD","LU2361044949.HKD","PLTY","SMCI","NOWX","SCHA","LU0472753341.HKD","LU2461242641.AUD","IE00BJTD4V19.USD","IE00BMPRXR70.SGD","LU1861558580.USD","LU0154245756.USD","LU1280957306.USD","LU0820561909.HKD","BK4167","LU0107464264.USD","LU1023059493.AUD","IE00BQXX3C00.GBP","SNDU","CNAV","LU0053671581.USD","LU0511384066.AUD","LU1989772923.USD","LU2357305700.SGD","LU0823434583.USD","SMCC","QQQG","LU2023250504.SGD","LU2236285917.USD","LU0640476718.USD","LU0278409577.USD","LU0788108826.HKD","LU0889566641.SGD","FMTL","IE00B19Z9P08.USD","LU1267930490.SGD","LU0081259029.USD","LU0130517989.USD","BK4533","LU0109391861.USD","BK4170","LU0330918003.SGD","BK4017","LU0055631609.USD","IE00BKVL7J92.USD","LU0719512351.SGD","NEM","CRM","IE00BJTD4N35.SGD","IE00BQXX3D17.EUR","LU0820561818.USD","LU0251131958.USD","LU0630314457.HKD","AGMI","EYES","LU0198837287.USD","SLVP","PLT","PLYY","BK4125","LU0648000940.SGD","LU2125909759.SGD","LU1923623000.USD","LU0310799852.SGD","LU2462611646.USD","PSKY","LU1267930227.SGD","LU0345780521.USD","LU0477156953.USD","BK4550","IE00BZ9MQY76.HKD","LU0689626769.HKD","LU0528227936.USD","LU0498741114.HKD","LU0251142724.SGD","IE00B894F039.SGD","LU0082616367.USD","LU2381873111.SGD","LU0368265764.SGD","AUAU","LU0477156797.USD","LU1316542783.SGD","LU0889565833.HKD","IE00BQXX3F31.USD","PTIR","SNDG","TMSL","GDMN","LU0234570918.USD","LU2360107168.USD","LU0234572021.USD","LU1989772840.SGD","LU0154245673.USD","BK4097","LU0052756011.USD","LU0054578231.USD","LU0069063385.USD","TRUM","IE00B19Z3581.USD","LU1548497426.USD","LU0708995401.HKD","LU1861215975.USD","BK4567","LU1323610961.USD","IE00B19Z9Z06.USD","WDNA","MRNA","LU2089284900.SGD","LU0498741890.SGD","LU1223083913.SGD","BK4543","LU0075056555.USD","LU2362540622.SGD","LU2290526834.HKD","LU1804176565.USD","LU0612318971.USD","LU0354030438.USD","LU0654597011.USD","PLTL","LU1791710400.SGD","LU2458330243.SGD","LU0266013472.USD","LU2028103732.USD","LU0266512127.USD","LU1201861165.SGD","LU0106261372.USD","LU0943347566.SGD","LU1116320901.HKD","LU0456854461.SGD","LU2458330169.SGD","IT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664838571","title":"Vertex Advances Share Buyback, Acquires 445,500 Shares by August","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838571","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838571?lang=en_us&edition=fundamental","pubTime":"2026-09-01 12:22","pubTimestamp":1788236545,"startTime":"0","endTime":"0","summary":"Vertex Corp. ( ($JP:5290) ) has provided an announcement. Vertex Corporation reported the progress of its ongoing share buyback program, authorized...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-advances-share-buyback-acquires-445500-shares-by-august?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-advances-share-buyback-acquires-445500-shares-by-august?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBE","LU2456880835.USD","LU1035775433.USD","BK4139","LU1430594728.SGD","ACKY","LU1069344957.HKD","LU0417517546.SGD","IE0002141913.USD","BRKC","GNMX","LU0061475181.USD","BK4588","IDNA","IE00BFTCPJ56.SGD","BRKD","LU1674673428.USD","LU1559883803.SGD","VRTX","BIB","LU2468319806.SGD","IBB","IBBQ","LU0320765992.SGD","LU0109394709.USD","VERX","BRKU","LU2362541513.USD","TBXU","IE00BZ9MQY76.HKD","BBH","LU0757428866.USD","BK4567","BRKW","LU0234570918.USD","SG9999001176.USD","ACTV","IE00BJJMRZ35.SGD","LU0058720904.USD","IE00B19Z9P08.USD","LU0889565916.HKD","LU2237438978.USD","LU1585245621.USD","LU2462157665.USD","BRKL","IE00BJT1NW94.SGD","LU0256863811.USD","LU1778281490.HKD","IE00B2B36J28.USD","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664838493","title":"Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838493","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838493?lang=en_us&edition=fundamental","pubTime":"2026-09-01 10:20","pubTimestamp":1788229256,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals has delivered strong long term gains over the past five years, yet current valuation checks suggest the stock now looks closer to fairly priced than clearly cheap. For investors, the question is how that past share price performance lines up with what the broader valuation signals are saying today.\n\nThe stock has returned 174.9% over five years, which puts extra focus on whether recent strength already reflects much of the good news in the story.\nFuture growth in cash...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/36235-main-header/1756253398031","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/36235-main-header/1756253398031"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/vertex-vrtx-stock-looks-reasonable-as-growth-must-justify-it","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/vertex-vrtx-stock-looks-reasonable-as-growth-must-justify-it","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","IE0009355771.USD","LU0061475181.USD","IE00B19Z3B42.SGD","SG9999001176.USD","VRTX","BK4585","LU0889565916.HKD","IE00BZ9MQY76.HKD","LU2417539215.USD","PBE","IE00B19Z3581.USD","BBH","BK4532","BIB","GNMX","LU1069344957.HKD","TBXU","BK4588","VERX","IE00B2B36J28.USD","LU1815336091.USD","IE0002141913.USD","LU1778281490.HKD","LU0823416689.USD","LU2089984988.USD","IBBQ","LU0234570918.USD","LU2324357040.USD","LU1674673691.USD","LU0432979614.USD","IE00B19Z9Z06.USD","CDIG","SG9999001176.SGD","LU1430594728.SGD","LU1559883803.SGD","LU2362540622.SGD","SGXZ57979304.SGD","LU0566484027.USD","LU1035775433.USD","LU0109394709.USD","LU1674673428.USD","LU0289739699.SGD","IE00BJJMRZ35.SGD","LU0079474960.USD","IBB","TSPA","TACU","IDNA","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664881893","title":"Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2664881893","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664881893?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:30","pubTimestamp":1788219000,"startTime":"0","endTime":"0","summary":"An Important Step Forward for Access to LEQEMBI for Eligible Patients in CanadaTOKYO and CAMBRIDGE, Mass., Aug.  31, 2026 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB), announced ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/31/3353756/0/en/canada-s-drug-agency-issues-final-positive-recommendation-supporting-public-reimbursement-of-leqembi-lecanemab-for-early-alzheimer-s-disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","HYLG","NVIB","SOCL","BMED","IDNA","MEDX","MCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883783","title":"Incyte Reaches CMS Pact on Jakafi Medicaid Pricing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883783","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883783?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:47","pubTimestamp":1788209252,"startTime":"0","endTime":"0","summary":"An announcement from Incyte ( ($INCY) ) is now available. Incyte Corporation said it has entered into an agreement with the U.S. Centers for Medica...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/incyte-reaches-cms-pact-on-jakafi-medicaid-pricing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/incyte-reaches-cms-pact-on-jakafi-medicaid-pricing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","BK4532","RSPH","BK4139","INCY","BK4550","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883188","title":"NeuroThera Labs Advances Enrollment in Autism Drug Trial for SCI-210","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883188","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883188?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:37","pubTimestamp":1788208671,"startTime":"0","endTime":"0","summary":"NeuroThera Labs Inc. ( ($TSE:NTLX) ) has issued an update. NeuroThera Labs reported strong enrollment momentum in its SCI-210 clinical trial for ch...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurothera-labs-advances-enrollment-in-autism-drug-trial-for-sci-210?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurothera-labs-advances-enrollment-in-autism-drug-trial-for-sci-210?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDX","NVIB","IDNA","GDOC","HYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883375","title":"Incyte - Expects Exemption from Future CMS Pricing Mandates Including Guard and Globe - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883375","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883375?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:30","pubTimestamp":1788208211,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0UW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IDNA","BK4585","INCY","BK4588","BK4550","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883311","title":"Incyte - Announces Agreement with CMS to Improve Medicine Access - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883311","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883311?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:30","pubTimestamp":1788208211,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0UW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4550","IDNA","BK4532","INCY","BK4585","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883310","title":"Incyte - State Medicaid to Access Jakafi and Jakafi Xr at Prices Aligned with Advanced Nations - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883310","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883310?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:30","pubTimestamp":1788208211,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0UW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","INCY","BK4532","BK4139","IDNA","BK4550","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664314883","title":"Incyte - Does not Expect Agreement to Affect 2026 Financial Guidance or Outlook - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664314883","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664314883?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:30","pubTimestamp":1788208211,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0UW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4550","BK4588","BK4139","BK4585","BK4532","INCY","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883858","title":"SciSparc subsidiary provides update on SCI-210 trial enrollment","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883858","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883858?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:10","pubTimestamp":1788207046,"startTime":"0","endTime":"0","summary":"SciSparc (SPRC)announced that NeuroThera Labs continued advancement in participant enrollment for the clinical trial assessing NeuroThera’s SCI-210...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scisparc-subsidiary-provides-update-on-sci-210-trial-enrollment-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scisparc-subsidiary-provides-update-on-sci-210-trial-enrollment-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","BK4007","MEDX","SPRC","BK4139","HYLG","GDOC","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664831883","title":"PMV Pharmaceuticals announces updated ovarian cancer data from PYNNACLE trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2664831883","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664831883?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:05","pubTimestamp":1788206710,"startTime":"0","endTime":"0","summary":"PMV Pharmaceuticals (PMVP) announced updated interim ovarian cancer data from the Phase 2 pivotal portion of the PYNNACLE clinical trial. The multi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pmv-pharmaceuticals-announces-updated-ovarian-cancer-data-from-pynnacle-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pmv-pharmaceuticals-announces-updated-ovarian-cancer-data-from-pynnacle-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDX","HYLG","IDNA","GDOC","PMVP","BK4139","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000652","title":"Cboe data suggests bullish flow in Moderna with shares up 0.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000652","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664000652?lang=en_us&edition=fundamental","pubTime":"2026-09-01 02:20","pubTimestamp":1788200410,"startTime":"0","endTime":"0","summary":"Cboe data suggests bullish flow in Moderna (MRNA), with shares up 98c, or 0.71%, near $138.97. Options volume relatively light with 62k contracts t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-moderna-with-shares-up-0-71-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-moderna-with-shares-up-0-71-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LGHT","BK4551","MRNY","BK4534","BK4588","IDNA","BK4585","WDNA","GNOM","MRNA","MRNX","BK4532","BK4568","BK4501","BK4533","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664200767","title":"Moderna Stock (MRNA) Was the Best Performer in August","url":"https://stock-news.laohu8.com/highlight/detail?id=2664200767","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664200767?lang=en_us&edition=fundamental","pubTime":"2026-09-01 01:18","pubTimestamp":1788196728,"startTime":"0","endTime":"0","summary":"Moderna’s ($MRNA) stock rose 152% in August, making it the best-performing security during the month.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/moderna-stock-mrna-was-the-best-performer-in-august?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/moderna-stock-mrna-was-the-best-performer-in-august?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LGHT","MRNY","BK4551","MRNA","BK4534","IDNA","BK4533","BK4588","BK4548","BK4532","BK4139","WDNA","MRNX","GNOM","BK4501","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663079265","title":"Revolution Medicines, Inc. : Needham Raises Target Price to $275 from $240","url":"https://stock-news.laohu8.com/highlight/detail?id=2663079265","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663079265?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:45","pubTimestamp":1788169510,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S00C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDNA","IE0009354923.USD","CANC","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0109394709.USD","IE00B4R5TH58.HKD","RVMD","LU0320765992.SGD","BK4139","IE0009355771.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","BBH","IE00BFTCPJ56.SGD","PTH","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663588047","title":"Protagonist announces Takeda received U.S. FDA approval for MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663588047","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663588047?lang=en_us&edition=fundamental","pubTime":"2026-08-31 04:35","pubTimestamp":1788122107,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX) announced that Takeda (TAK) received U.S. Food and Drug Administration, FDA, approval for MIMRYLO, a subcutaneously...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IYH","RSPH","BK4585","TBXU","TAK","BK4139","SYNB","PINK","GNMX","XLVX","PSCH","IBB","BBP","BK4007","FRTY","TECB","MRNY","MEDI","IEIH","MRNX","LFSC","NVIB","LABU","PTGX","BK4588","IDNA","GDOC","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663404203","title":"Tenax Therapeutics announces results from Phase 3 LEVEL trial of TNX-103","url":"https://stock-news.laohu8.com/highlight/detail?id=2663404203","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663404203?lang=en_us&edition=fundamental","pubTime":"2026-08-31 03:35","pubTimestamp":1788118510,"startTime":"0","endTime":"0","summary":"Tenax Therapeutics (TENX) announced that additional results from the Phase 3 LEVEL clinical trial evaluating TNX-103 in patients with pulmonary hyp...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tenax-therapeutics-announces-results-from-phase-3-level-trial-of-tnx-103-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tenax-therapeutics-announces-results-from-phase-3-level-trial-of-tnx-103-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GDOC","IDNA","LENZ","BK4007","NVIB","HYLG","TENX","MEDX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663562049","title":"Incyte (INCY) Stock Could Be 31% Stretched Following KRAS Data Buzz","url":"https://stock-news.laohu8.com/highlight/detail?id=2663562049","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663562049?lang=en_us&edition=fundamental","pubTime":"2026-08-30 15:21","pubTimestamp":1788074461,"startTime":"0","endTime":"0","summary":"Incyte stock has delivered a strong 92.3% gain over the past three years, yet current valuation checks suggest investors may be paying a premium to the intrinsic value estimate while traditional multiples look more in line with peers. The result is a stock that no longer looks obviously cheap, even after a solid multi year run.\n\nIncyte has returned 92.3% over three years, which puts more pressure on today’s valuation to be supported by future cash flows rather than past share price...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-incy/incyte/news/incyte-incy-stock-could-be-31-stretched-following-kras-data","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-incy/incyte/news/incyte-incy-stock-could-be-31-stretched-following-kras-data","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4532","INCY","BK4588","SPHQ","BK4139","DCF","BK4585","IDNA","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177566071","title":"August Turmoil: Bessent's Intervention and the Quiet Reveal of Policy's Hidden Hand","url":"https://stock-news.laohu8.com/highlight/detail?id=1177566071","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177566071?lang=en_us&edition=fundamental","pubTime":"2026-08-30 13:40","pubTimestamp":1788068423,"startTime":"0","endTime":"0","summary":"August was expected to be a quiet month for markets, yet it has instead become a profound release of policy signals.US Treasury Secretary Scott Bessent has intervened in both the dollar-yen exchange...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1718418525.SGD","LU0211327993.USD","LU1989764748.USD","BK4579","LU0211328371.USD","SG9999014575.USD","LU1242518857.USD","NVD","LU1066053197.SGD","LU0788109477.HKD","LU2420271590.USD","LU1119994496.HKD","IE0009G5SDU7.USD","LU2430703178.SGD","LU2471134523.USD","HK0000306701.USD","IE00BZ199S13.USD","LU2552382058.USD","SG9999002224.SGD","LU0082616367.USD","TTEQ","LU0965508806.USD","NVD2.UK","SG9999014906.USD","LU1868836914.USD","LU1645745479.HKD","LU1988902786.USD","BK4581","BK4614","LU2756315664.SGD","SGXZ23171101.USD","LU2361044865.SGD","LU2433249047.HKD","IE00B4YYXB79.USD","LU1633808545.USD","LU0528227936.USD","LU0661504455.SGD","BK4543","CHPX","LU1242518931.SGD","LU1244550494.USD","LU0345768153.USD","NVDD","LU2168564149.EUR","LU0823434583.USD","LU2471134952.CNY","LU1935042488.USD","LU0265550359.USD","IE00BHPRN162.USD","LU2097344357.USD","LU0787776722.HKD","LU2247934214.USD","LU2272731782.SGD","EFIV","LU2237443549.SGD","NVDL","LU2471134796.USD","SG9999014914.USD","LU2087621335.USD","LU2505996681.GBP","IE00B19Z8W00.USD","LU2463028550.USD","BK4598","HK0000532082.HKD","NVD3.UK","LU2347655156.SGD","TRFK","LU0965509283.SGD","LU1267930573.SGD","LU1400636491.USD","LU0823414551.USD","LU0347712357.USD","LU0109392836.USD","LU0726765562.USD","LU1496350502.SGD","LU2063271972.USD","LU0175139822.USD","LU0965509010.AUD","LU2237438978.USD","LU2211815571.USD","LU2357305700.SGD","3NVD.UK","IE0005OL40V9.USD","LU0553294199.USD","LU2089985449.USD","MRNY","LU2092937148.SGD","LU0158827948.USD","LU2361044949.HKD","LU0868494708.USD","LU0912757837.SGD","LU0472753341.HKD","IE00BMPRXR70.SGD","IGV","LU2023251221.USD","LU1804176565.USD","LU2272731600.USD","LU2746668461.USD","TEK","LU2244417387.USD","LU2065171402.SGD","LU0048584097.USD","LU0225283273.USD","IE00BJJMRY28.SGD","LU2242649171.HKD","IE0034235188.USD","LU1791710400.SGD","LU0390134368.USD","LU2125909759.SGD","LU0081259029.USD","LU1814569148.SGD","LU2290526834.HKD","LU0210536198.USD","LU1699723380.USD","LU0203202063.USD","LU2125154778.USD","LU0266013472.USD","SG9999000418.SGD","BK4141","LU1720051017.SGD","LU1366333091.USD","LU0342679015.USD","LU1153585028.USD","LU0889565833.HKD","BK4592","LU1951200564.SGD","LU1979441026.SGD","LU2237443895.HKD","NVDG","IE00B7KXQ091.USD","LU1868836591.USD","LU0251132253.USD","LU2148611432.USD","LU2602419157.SGD","LU2505996509.AUD","LU1868836757.USD","IE00B3SWFQ91.USD","LU1400636574.HKD","SG9999015986.USD","LU0353189763.USD","LU0957808578.USD","LU2360107168.USD","HK0000914660.USD","LU0265550946.USD","IE0003U64NQ7.SGD","LU2462157665.USD","LU2089284900.SGD","SOXX","SMH","LU2746668974.SGD","IE00BQXX3C00.GBP","BK4587","LU0061474705.USD","LU2237957811.SGD","LU0823434740.USD","USXF","LU1852331112.SGD","LU0476273544.USD","IE00B1XK9C88.USD","SG9999002232.USD","LU0719512351.SGD","LU2487616109.SGD","SG9999015978.USD","LU1116320901.HKD","LU2462591350.SGD","IE0004086264.USD","LU1037948897.HKD","LU2394011477.USD","LU2023250504.SGD","SG9999001424.SGD","BK4608","LU2237443382.USD","IE00BN29S564.USD","LU2381873111.SGD","SHOC","LU1144417596.USD","LU0158827781.USD","LU0323591593.USD","IE00BMPRXN33.USD","LU2097344431.USD","SG9999014898.SGD","LU1935043536.SGD","LU0069063385.USD","LU0724617625.USD","LU0354030438.USD","LU0868494617.USD","NVIW.SI","LU0256863811.USD","LU2242650005.HKD","LU1815333072.USD","LU2100268510.USD","GAMR","LU0107464264.USD","IE00BJTD4V19.USD","LU1815336760.USD","LU1914381329.SGD","LU2106854487.HKD","LU2360106780.USD","LU1244550221.USD","LU0133085943.USD","IETC","LU1732800096.USD","LU1861215975.USD","LU2417539215.USD","IDNA","LU0820561818.USD","HK0000914686.HKD","LU1917777945.USD","IE00BZ1G4Q59.USD","IE00BD6J9T35.USD","LU1992135399.USD","SNVD.UK","LU0683600562.USD","LU2083900584.USD","LU0061474960.USD","LU0882574139.USD","LU2491050154.USD","LU0942090050.USD","LU1145028129.USD","LU0642271901.SGD","LU0096364046.USD","LU2430703251.USD","LU2249611893.SGD","FAI","LU2896262040.SGD","LU0557290698.USD","LU2592432038.USD","LU0079474960.USD","LU2931357623.SGD","NVDA","LU2168564065.EUR","LU1935043023.USD","LU2237443978.SGD","LU0234570918.USD","LU0708995401.HKD","LU2750360997.AUD","NVDO","LU0097036916.USD","SGXZ51526630.SGD","LGHT","LU0203201768.USD","LU1244550577.SGD","LU2237957902.USD","LU1989764664.SGD","GB00BDT5M118.USD","IE0004445239.USD","LU1992135472.HKD","LU1923622291.USD","USD","LU0215105999.USD","LU2237443465.HKD","LU2491050071.SGD","LU0128525929.USD","LU2054465674.USD","LU2471134879.HKD","SG9999017495.SGD","LU0080751232.USD","LU0861579265.USD","NVC","IE00BKDWB100.SGD","LU0795875169.SGD","LU1880398554.USD","NVDX","BK4139","LU1003077747.HKD","SG9999014880.SGD","LU0738911758.USD","NVDB","SG9999015945.SGD","LU0511384066.AUD","LU0444973449.USD","BK4568","BK4612","LU0395794307.EUR","LU0210528500.USD","LU1323610961.USD","BK4588","LU0345770308.USD","LU1066051225.USD","SG9999014559.SGD","CLSE","LU2461242641.AUD","LU0640476718.USD","LU0708994859.HKD","LU0234572021.USD","HK0000320264.USD","LU1035775433.USD","LU1642822529.SGD","NVDU","LU2191332357.HKD","MRNA","LU1435385759.SGD","BK4503","LU1267930730.SGD","IE00B5949003.HKD","LU1670756490.USD","IE00BJLML261.HKD","2NVD.UK","LU0124676726.USD","LU0289960550.SGD","LU0061475181.USD","LU0820561909.HKD","NVDY","LU0348723411.USD","LU0345769128.USD","HK0000304797.USD","LU2750360641.GBP","LU1551013425.SGD","LU1935042991.SGD","LU0174119429.USD","LU0979878070.USD","LU0057025933.USD","CNEQ","LU1116320737.USD","LU2456880835.USD","LU0256863902.USD","LU1720051108.HKD","IE00BKPKM429.USD","BK4534","BK4501","LU2065170008.USD","WDNA","SG9999004303.SGD","LU0323239441.USD","LU0672654240.SGD","LU1974910355.USD","AIFD","LU1839511570.USD","IE00B19Z8X17.USD","LU2403377893.USD","LU2236285917.USD","LU2322448957.HKD","LU0187121727.USD","IE00BWXC8680.SGD","LU0127658192.USD","SGXZ31699556.SGD","LU0957791311.USD","FDTX","LU0138981039.USD","LU0096362180.USD","BK4551","LU2108987350.USD","LU1934455194.USD","LU0109391861.USD","FTEC","LU2506951792.HKD","LU0289961442.SGD","LU2322448791.USD","SGXZ81514606.USD","LU1035773651.USD","LU2133065610.SGD","LU1923623000.USD","LU2954938101.SGD","LU0823421333.USD","THMR","ESLG","LU2637965513.SGD","LU1261432733.SGD","LU2125909593.SGD","LU2264538146.SGD","LU1721428933.USD","IE00BQXX3F31.USD","IE00BDCRKT87.USD","LU2089283258.USD","IE000W1ABFV2.USD","NVDQ","LU1983260115.SGD","LU1791710582.SGD","BK4549","LU0106261372.USD","LU2491049909.HKD","LU0545039389.USD","IE00BK4W5M84.HKD","LU0276348264.USD","LU0964807845.USD","BK4529","LU1496350171.SGD","IE00B1BXHZ80.USD","IE0001KFT4U8.USD","LU1880398471.USD","LU2125909247.SGD","NVDS.UK","LU2077746001.SGD","LU0053666078.USD","LU0345769631.USD","LU2552382132.HKD","LU0006306889.USD","LU1069344957.HKD","GNOM","LU0267386448.USD","ABFL","LU1037948541.HKD","LU2357125470.USD","SG9999014567.USD","IE00BK4W5L77.USD","IE00BJTD4N35.SGD","LU1280957306.USD","LU0949170772.SGD","LU1934455863.HKD","SOXY","LU0308772762.SGD","IE0009356076.USD","LU0238689110.USD","LU2065171311.SGD","LU1366192091.USD","LU1127390331.HKD","IE00B4JS1V06.HKD","AIPI","LU0154236417.USD","LU0689472784.USD","LU1571399168.USD","LU1674673691.USD","LU2168563687.JPY","TYLG","LU2413666699.HKD","LU1084165304.USD","LU0965509101.SGD","LU2543165471.USD","SG9999018857.SGD","IE000ITXATA3.USD","LU0198837287.USD","LU2361045086.USD","LU0820562030.AUD","LU1064131342.USD","LU3102509885.SGD","SOXQ","LU1951198990.SGD","LU0345770993.USD","IE0004091025.USD","LFGY","IE0004445015.USD","SNPE","LU2213496289.HKD","JGRO","LU0985320562.USD","LU2452424414.USD","LU0056508442.USD","LU0494093205.USD","LU0274383776.USD","LU2028103732.USD","LU0689626769.HKD","TTXU","IE00B3M56506.USD","LU1316542783.SGD","SNVDAmain","LU0444971666.USD","07788","IE00BYXW3230.USD","LU1400636657.SGD","SGXZ80539844.SGD","LU0345768740.USD","LU1629891620.HKD","IE00B19Z9505.USD","BK4605","LU0170899867.USD","LU1551013342.USD","LU1267930490.SGD","SG9999014542.SGD","LU2473716301.USD","NVDW","LU0094547139.USD","LU2125154935.USD","IE000Q6AESB8.SGD","BK4532","LU1868837300.USD","LU1803068979.SGD","IE000YTNTUN2.SGD","BK4550","IE00B775H168.HKD","LU0143551892.USD","IXN","BK4554","LU0310800379.SGD","LU0289739343.SGD","NVDS","BK4567","LU1923622614.USD","IE0034235295.USD","LU1623119135.USD","LU2430703095.HKD","SG9999015952.SGD","LU1674673428.USD","IE00BQXX3D17.EUR","LU0323240290.USD","HK0000304805.HKD","LU2413666426.HKD","LU1066051811.HKD","LU1861220033.SGD","IE00BMPRXQ63.HKD","IE00BDRTCR15.USD","LU2860962120.EUR","LU0077335932.USD","IE00BFSS7M15.SGD","LU2237443622.USD","NVII","LU2047632596.USD","LU2272731865.HKD","LU2087625088.SGD","NVYY","HK0000320223.HKD","LU0320765059.SGD","LU1069347547.HKD","LU0310799852.SGD","LU1935042215.USD","XLK","LU1934455277.USD","SG9999015358.SGD","WISE","LU2168564495.EUR","07388","LU0823414478.USD","LU2092627202.USD","LU0354030511.USD","MRNX","AGOX","BK4533","DIPS","IE000KEQY171.SGD","LU0157215616.USD","HK0000819398.USD","LU1429558221.USD","LU1712237335.SGD","METV","LU2168564222.USD","BK4527","SPTE","LU0029864427.USD","IE0034235303.USD","LU2023250330.USD","LU0353189680.USD","IE00BJJMRX11.SGD","LU2462591277.SGD","LU2065169927.USD","BK4585","LU2552382215.SGD","LU1861127337.USD","LU2458330169.SGD","LU2294711713.HKD","ANV","LU2756315318.SGD","VGT","IE00BFSS8Q28.SGD","LU0786609619.USD","LU1868837136.USD","LU0210533765.USD","LU0943347566.SGD","LU0795875086.SGD","LU1202635105.USD","LU2279689827.SGD","LU2458330243.SGD","SG9999015341.SGD","IE00B775SV38.USD","BK4548","ROM","LU2265009873.SGD","LU0417517546.SGD","SMHX","NULC","LU1989772840.SGD","LU1232071149.USD","LU1548497426.USD","LU2111349929.HKD","LU1821325948.USD","IE00B5TLWC47.USD","LU1778281490.HKD","LU1691799644.USD","LU0823421416.USD","IE00BKVL7J92.USD","LU1732799900.SGD","LU2326559502.SGD","LU0316494557.USD","LU2999663052.SGD","LU2271345857.HKD","SGXZ99366536.SGD","LU1989772923.USD","LU2360032135.SGD","SG9999018865.SGD","IE00B3S45H60.SGD","LU2286300806.USD","ILDR","LU0072462426.USD","LU1066051498.USD","CMAG","VT","LU0070217475.USD","LU2250418816.HKD","LU2125909916.SGD","HK0000306685.HKD","LU0466842654.USD","ESUM","LU2347655073.USD","LU0011850046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663464017","title":"Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Spyre Therapeutics (SYRE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2663464017","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663464017?lang=en_us&edition=fundamental","pubTime":"2026-08-29 22:30","pubTimestamp":1788013830,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and Spyre Therapeutics (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0128526141.USD","LFSC","XLV","BBH","LU0029874061.USD","PTH","LU0320765992.SGD","XBI","IE0009354923.USD","IE00BFTCPJ56.SGD","LABU","IE00BJT1NW94.SGD","BK4588","BK4585","IE00BJJMRZ35.SGD","IE0009355771.USD","IDNA","BK4139","IE00B4R5TH58.HKD","BK4581","HCSG","LU0889565916.HKD","IE0002141913.USD","IE00B2B36J28.USD","RVMD","LU0109394709.USD","SYRE","CANC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":16,"pageCount":2,"totalSize":320,"code":"91000000","status":"200"}]}}